Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach

Christopher R. Dunston, Rebecca Herbert, Helen R. Griffiths

Research output: Contribution to journalArticle

Abstract

Prophylactic vaccines are an effective strategy to prevent development of many infectious diseases. With new and re-emerging infections posing increasing risks to food stocks and the health of the population in general, there is a need to improve the rationale of vaccine development. One key challenge lies in development of an effective T cell-induced response to subunit vaccines at specific sites and in different populations. Objectives: In this review, we consider how a proteomic systems-based approach can be used to identify putative novel vaccine targets, may be adopted to characterise subunit vaccines and adjuvants fully. Key findings: Despite the extensive potential for proteomics to aid our understanding of subunit vaccine nature, little work has been reported on identifying MHC 1-binding peptides for subunit vaccines generating T cell responses in the literature to date. Summary: In combination with predictive and structural biology approaches to mapping antigen presentation, proteomics offers a powerful and as yet un-tapped addition to the armoury of vaccine discovery to predict T-cell subset responses and improve vaccine design strategies.

LanguageEnglish
Pages290-299
Number of pages10
JournalJournal of Pharmacy and Pharmacology
Volume67
Issue number3
Early online date23 Feb 2015
DOIs
Publication statusPublished - 2015

Fingerprint

Subunit Vaccines
Systems Analysis
Proteomics
Vaccines
T-Lymphocytes
Antigen Presentation
T-Lymphocyte Subsets
Population
Communicable Diseases
Food
Health
Infection

Bibliographical note

This is the peer reviewed version of the following article: Dunston, CR, Herbert, R & Griffiths, HR 2015, 'Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach' Journal of pharmacy and pharmacology, vol 67, no. 3, pp. 290-299, which has been published in final form at http://dx.doi.org/10.1111/jphp.12383. This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

Keywords

  • biotechnology and drug discovery
  • rational vaccine design

Cite this

Dunston, Christopher R. ; Herbert, Rebecca ; Griffiths, Helen R. / Improving T cell-induced response to subunit vaccines : opportunities for a proteomic systems approach. In: Journal of Pharmacy and Pharmacology. 2015 ; Vol. 67, No. 3. pp. 290-299.
@article{ca581387788147bd8a6f8f13ed5c6234,
title = "Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach",
abstract = "Prophylactic vaccines are an effective strategy to prevent development of many infectious diseases. With new and re-emerging infections posing increasing risks to food stocks and the health of the population in general, there is a need to improve the rationale of vaccine development. One key challenge lies in development of an effective T cell-induced response to subunit vaccines at specific sites and in different populations. Objectives: In this review, we consider how a proteomic systems-based approach can be used to identify putative novel vaccine targets, may be adopted to characterise subunit vaccines and adjuvants fully. Key findings: Despite the extensive potential for proteomics to aid our understanding of subunit vaccine nature, little work has been reported on identifying MHC 1-binding peptides for subunit vaccines generating T cell responses in the literature to date. Summary: In combination with predictive and structural biology approaches to mapping antigen presentation, proteomics offers a powerful and as yet un-tapped addition to the armoury of vaccine discovery to predict T-cell subset responses and improve vaccine design strategies.",
keywords = "biotechnology and drug discovery, rational vaccine design",
author = "Dunston, {Christopher R.} and Rebecca Herbert and Griffiths, {Helen R.}",
note = "This is the peer reviewed version of the following article: Dunston, CR, Herbert, R & Griffiths, HR 2015, 'Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach' Journal of pharmacy and pharmacology, vol 67, no. 3, pp. 290-299, which has been published in final form at http://dx.doi.org/10.1111/jphp.12383. This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.",
year = "2015",
doi = "10.1111/jphp.12383",
language = "English",
volume = "67",
pages = "290--299",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "3",

}

Improving T cell-induced response to subunit vaccines : opportunities for a proteomic systems approach. / Dunston, Christopher R.; Herbert, Rebecca; Griffiths, Helen R.

In: Journal of Pharmacy and Pharmacology, Vol. 67, No. 3, 2015, p. 290-299.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Improving T cell-induced response to subunit vaccines

T2 - Journal of Pharmacy and Pharmacology

AU - Dunston, Christopher R.

AU - Herbert, Rebecca

AU - Griffiths, Helen R.

N1 - This is the peer reviewed version of the following article: Dunston, CR, Herbert, R & Griffiths, HR 2015, 'Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach' Journal of pharmacy and pharmacology, vol 67, no. 3, pp. 290-299, which has been published in final form at http://dx.doi.org/10.1111/jphp.12383. This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

PY - 2015

Y1 - 2015

N2 - Prophylactic vaccines are an effective strategy to prevent development of many infectious diseases. With new and re-emerging infections posing increasing risks to food stocks and the health of the population in general, there is a need to improve the rationale of vaccine development. One key challenge lies in development of an effective T cell-induced response to subunit vaccines at specific sites and in different populations. Objectives: In this review, we consider how a proteomic systems-based approach can be used to identify putative novel vaccine targets, may be adopted to characterise subunit vaccines and adjuvants fully. Key findings: Despite the extensive potential for proteomics to aid our understanding of subunit vaccine nature, little work has been reported on identifying MHC 1-binding peptides for subunit vaccines generating T cell responses in the literature to date. Summary: In combination with predictive and structural biology approaches to mapping antigen presentation, proteomics offers a powerful and as yet un-tapped addition to the armoury of vaccine discovery to predict T-cell subset responses and improve vaccine design strategies.

AB - Prophylactic vaccines are an effective strategy to prevent development of many infectious diseases. With new and re-emerging infections posing increasing risks to food stocks and the health of the population in general, there is a need to improve the rationale of vaccine development. One key challenge lies in development of an effective T cell-induced response to subunit vaccines at specific sites and in different populations. Objectives: In this review, we consider how a proteomic systems-based approach can be used to identify putative novel vaccine targets, may be adopted to characterise subunit vaccines and adjuvants fully. Key findings: Despite the extensive potential for proteomics to aid our understanding of subunit vaccine nature, little work has been reported on identifying MHC 1-binding peptides for subunit vaccines generating T cell responses in the literature to date. Summary: In combination with predictive and structural biology approaches to mapping antigen presentation, proteomics offers a powerful and as yet un-tapped addition to the armoury of vaccine discovery to predict T-cell subset responses and improve vaccine design strategies.

KW - biotechnology and drug discovery

KW - rational vaccine design

UR - http://www.scopus.com/inward/record.url?scp=84925805650&partnerID=8YFLogxK

U2 - 10.1111/jphp.12383

DO - 10.1111/jphp.12383

M3 - Article

VL - 67

SP - 290

EP - 299

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 3

ER -